TY - JOUR
T1 - HIV-1 gp160 as a Modifier of Th1 and Th2 Cytokine Response
T2 - Gp160 Suppresses Interferon-γ and Interleukin-2 Production Concomitantly with Enhanced Interleukin-4 Production in Vitro
AU - Hu, Rong
AU - Oyaizu, Naoki
AU - Kalyanaraman, Vaniambadi S.
AU - Pahwa, Savita
N1 - Copyright:
Copyright 2017 Elsevier B.V., All rights reserved.
PY - 1994/11
Y1 - 1994/11
N2 - Disease progression in HIV-1 infection is reported to be associated with a gradual shift in CD4+ T cell function from a Th type 1 to a Th type 2 of response, but the underlying mechanism remains unclear. In this study, the effect of HIV-1 envelope glycoprotein gp160 on secretion of cytokines IFN-γ/IL-2 (Th1 type) and IL-4 (Th2 type) was analyzed using freshly isolated unfractioned peripheral blood mononuclear cells (PBMC), CD4+ T cell lines, and PBMC depleted of CD8+ cells (CD8- PBMC) as target cells. Pretreatment of these cells with HIV gp160 significantly reduced PHA-induced secretion of IFN-γ and IL-2 but augmented IL-4 production. This effect of gp160 was not observed when the target cells consisted of PBMC depleted of either CD4+ cells (CD4- PBMC) or of CD2+ cells (CD2- PBMC). Pretreatment of gp160 with soluble CD4-immunoglobulin chimeric molecules abrogated the observed effects of gp160, suggesting that CD4-gp120 interaction is required for modification of the cytokine secretion profile. Our results suggest that exposure of CD4+ T cells to HIV-1 envelope proteins may modify the responses evoked by additional stimuli in favor of a Th2-type dominant response.
AB - Disease progression in HIV-1 infection is reported to be associated with a gradual shift in CD4+ T cell function from a Th type 1 to a Th type 2 of response, but the underlying mechanism remains unclear. In this study, the effect of HIV-1 envelope glycoprotein gp160 on secretion of cytokines IFN-γ/IL-2 (Th1 type) and IL-4 (Th2 type) was analyzed using freshly isolated unfractioned peripheral blood mononuclear cells (PBMC), CD4+ T cell lines, and PBMC depleted of CD8+ cells (CD8- PBMC) as target cells. Pretreatment of these cells with HIV gp160 significantly reduced PHA-induced secretion of IFN-γ and IL-2 but augmented IL-4 production. This effect of gp160 was not observed when the target cells consisted of PBMC depleted of either CD4+ cells (CD4- PBMC) or of CD2+ cells (CD2- PBMC). Pretreatment of gp160 with soluble CD4-immunoglobulin chimeric molecules abrogated the observed effects of gp160, suggesting that CD4-gp120 interaction is required for modification of the cytokine secretion profile. Our results suggest that exposure of CD4+ T cells to HIV-1 envelope proteins may modify the responses evoked by additional stimuli in favor of a Th2-type dominant response.
UR - http://www.scopus.com/inward/record.url?scp=0028115046&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0028115046&partnerID=8YFLogxK
U2 - 10.1006/clin.1994.1194
DO - 10.1006/clin.1994.1194
M3 - Article
C2 - 7523014
AN - SCOPUS:0028115046
VL - 73
SP - 245
EP - 251
JO - Clinical Immunology
JF - Clinical Immunology
SN - 1521-6616
IS - 2
ER -